Overview of Dr. Wang
Dr. Tony Wang is the Co-Director of the Center for Radiosurgery, Chair of the Quality and Patient Safety Committee in Radiation Oncology at New York Presbyterian/Columbia University Irving Medical Center, and Professor of Radiation Oncology (in Neurological Surgery) at Columbia University Irving Medical Center. He is recognized internationally for his extensive expertise in malignant and benign brain tumors. His research interests are in Gamma Knife stereotactic radiosurgery and brain tumors resulting in over 100 peer-reviewed publications. He has given over 50 invited lectures and visiting professorships nationally and internationally.
He serves on several national and international working groups developing guidelines for brain tumor management and stereotactic radiosurgery. He is an editor for 2 radiation oncology textbooks and a writer for over 15 book chapters. He serves as an Editor of Translational Cancer Research, Assistant Editor on the Radiosurgery & Radiation Oncology Section of Neurosurgery, the official journal of the Congress of Neurological Surgeons, and as a reviewer for JAMA Oncology, Journal of Clinical Oncology, and International Journal of Radiation Oncology, Biology, and Physics as well as many others
Dr. Wang received his B.A. and M.D. degrees from University of Missouri Kansas City Medical School, during which time he was also a Clinical Research Training Program Fellow at the National Institutes of Health, Bethesda, Maryland. He received internship training at Flushing Hospital Medical Center. Dr. Wang received his radiation oncology training at New York Presbyterian Hospital (Columbia campus), where he was Chief Resident from 2011-2012.
As a member of the Brain Tumor Center and Pituitary Tumor Center at Columbia, Dr. Wang is part of a multidisciplinary team that brings expertise from multiple specialties, including neurosurgery, neuro-oncology, neuroradiology, and neuro-endocrinology.
Office
622 W 168th St
# B-11
New York, NY 10032Fax+1 212-342-0637
Education & Training
- New York Presbyterian Hospital (Columbia Campus)Residency, Radiation Oncology, 2008 - 2012
- Flushing Hospital Medical CenterInternship, Transitional Year, 2007 - 2008
- University of Missouri Kansas City School of MedicineClass of 2007
- National Cancer InstitutePost-Doctoral Fellowship, 2005 - 2006
Certifications & Licensure
- FL State Medical License 2020 - Present
- CA State Medical License 2010 - 2026
- CT State Medical License 2022 - 2025
- NJ State Medical License 2022 - 2025
- NY State Medical License 2008 - 2025
- PA State Medical License 2023 - 2024
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- New York Super Doctors 2022-2024
- Editorial Board Neurosurgery, 2018-2024
- New York Magazine: Top Doctors Castle Connolly, 2017, 2021-2024
- Join now to see all
Clinical Trials
- Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Start of enrollment: 2014 Oct 27
- Memantine Hydrochloride and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Reducing Neurocognitive Decline in Patients With Brain Metastases Start of enrollment: 2015 Jul 01
- Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer Start of enrollment: 2015 Dec 07
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsSalvage Stereotactic Radiosurgery for Recurrent WHO Grade 2 and 3 Meningiomas: A Multicenter Study (STORM).Matthew Gallitto, Geoffrey Sedor, Albert Lee, Jared Pasetsky, Connor J Kinslow
International Journal of Radiation Oncology, Biology, Physics. 2024-11-01 - 2 citationsTyrosine Kinase Inhibitors With and Without Up-Front Stereotactic Radiosurgery for Brain Metastases FromandOncogene-Driven Non-Small Cell Lung Cancer (TURBO-NSCLC).Luke R G Pike, Emily Miao, Lillian A Boe, Tejas Patil, Brandon S Imber
Journal of Clinical Oncology. 2024-10-20 - The IDH paradox: Meta-analysis of alkylating chemotherapy in IDH-wild type and -mutant lower grade gliomas.Connor J Kinslow, Soumyajit Roy, Fabio M Iwamoto, Paul D Brown, David M DeStephano
Neuro-Oncology. 2024-10-03
Journal Articles
- Interdisciplinary management of acoustic neuromasSaadatmand HJ, Wu CC, Wang TJ, Applied Radiation Oncology, 3/2016
- Diffusion-weighted imaging of the brain for glioblastoma: implications for radiation oncoogyYanagihara TK, Wang TJ, Applied Radiation Oncology, 12/2014
- Nasopharyngeal carcinoma: current treatment options and future directionsSaad S, Wang TJ, Journal of Nasopharyngeal Carcinoma, 9/29/2014
- Join now to see all
Books/Book Chapters
Authored Content
- The Rising Need for Faculty Mentoring in Academic MedicineMay 2017
Press Mentions
- Smarter Radiation Therapy Enhances Personalized Care for Cancer PatientsDecember 6th, 2021
- Treatment for Overactive Thyroid Linked to Increased Risk of Dying from CancerJuly 1st, 2019
- Short-Course RT Helps Retain Ability to Walk in Advanced CaJune 4th, 2017
- Join now to see all
Grant Support
- An Open-Label Phase II Study of Atezolizumab, Tocilizumab and Temozolomide with Radiotherpay in Patients with newly Diagnosed Glioblastoma without PTEN loss or mutationMusella Foundation for Brain Tumor Research & Information2020–Present
- Radiosensitization of glioblastoma by cannabinoidsColumbia University Medical Center / Radiation Oncology RFA2018–2019
- A Randomized, Placebo Controlled Phase 3 Study of ABT-414 With Concurrent Chemoradiation and Adjuvant Temozolomide in Subjects With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Rec.RTOG Foundation2015–2018
- Phase I Feasibility Trial for the Role of Cannabis in Patients with Glioblastoma Treated with Radiation and TemozolomideIrving Institute for Clinical and Translational Research2015–2016
- Highly Diffusion-Weighted Imaging: A Predictive Marker in GlioblastomaIrving Institute for Clinical and Translational Research2015–2016
Committees
- Member, American Board of Radiology Adult Central Nervous System and Pediatric Cancer Committee 2018 - Present
- Member, American Radium Society-American College of Radiology Appropriateness Criteria Brain Committee 2018 - Present
- Member, Columbia University Vagelos College of Physicians and Surgeons Admissions Interview Committee 2018 - Present
- Member, NRG Brain Tumor Core Committee 2017 - Present
- Member, SWOG Radiation Oncology Committee 2015 - Present
- Temporary Member, NIH Clinical Oncology Study Section (CONC) 2018 - 2018
- Fellow, Doximity 2016 - 2017
- Physician Panelist, Doximity 2015 - 2016
Professional Memberships
- Member
- Member
- Society for Neuro-OncologyMember
Other Languages
- Chinese (Mandarin)
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
CIGNA HMO
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
GHI PPOHIP of New York - Select PPO
Horizon BCBS PPO
MagnaCare PPO
Oxford Health Freedom
Oxford Health Liberty
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: